Uzedy risperidone patent expiry?

When does Uzedy (risperidone) patent protection expire?

Uzedy is a long-acting injectable (LAI) risperidone product, but the exact “patent expiry” date depends on which type of protection you mean (drug patent, formulation/patent for the delivery system, or any later-introduced exclusivities). Patent expiry and marketed-product exclusivity can also differ by country.

What’s the difference between “patent expiry” and “exclusivity” for Uzedy?

For products like Uzedy, users often mix up two timelines:
- Patent expiry: the last date a listed patent can block generic or biosimilar competition in that jurisdiction.
- Regulatory exclusivity (if applicable): time-limited protection granted by the regulator that can delay approval of competing products even if a specific patent expires earlier or is challenged.

How do manufacturers challenge or delay Uzedy competition?

In practice, companies seeking to launch a competing product may rely on:
- Patent challenges or non-infringement arguments in court
- Carve-outs or design changes to avoid specific claims
- Waiting for the latest-expiring patent or the end of applicable regulatory exclusivity

Which country’s expiry date do you want?

Uzedy’s patent and exclusivity dates can vary substantially by market (for example, U.S. vs. EU vs. UK vs. other countries). If you tell me the country (and whether you want “latest patent expiry” or “when generics/biosimilars can enter”), I can narrow the timeline accordingly.

Sources: None provided in the prompt.